Open in interactive viewer → charts, metric popovers & call review

Big Sky Industrial Wants a 17x Multiple. It's Still Living on $2.9 Million of Cash.

Phase 1's field work is finished and the helium is contracted at $285/Mcf — but first production has slid from early 2026 to spring 2027, and the EPA still holds the 45Q keys.
USEG · Earnings Call · 2026-11-11

The rebrand is the thesis

The operator did not open this call for U.S. Energy Corp. It opened it for Big Sky Industrial, Inc. That is not a slip of the tongue — the investor relations site printed on the disclaimer is bigskyindustrialinc.com, and the self-description has been rewritten accordingly. The ticker is still USEG, the sector field still reads Oil & Gas E&P, and the market cap is $44 million. But what management is selling is no longer an oil company. By the CEO's own framing, the third quarter was about one thing: “The field side of Phase 1 is now built.” — Ryan Smith, CEO · 2026-11-11 Infield gathering and injection lines are complete, the production wells are drilled and ready to tie in, the Class II injection wells are operational, and the long-lead equipment — including company-owned natural gas generators — is bought and on site. Fabrication of the modular processing plant is underway with the EPC partner, on-site civil work starts in weeks, and the target is first production in spring 2027 with helium sold from day one. The commercial side is genuinely unusual for a $44 million company. The April offtake is a five-year, 100% take-or-pay contract with an investment-grade global industrial gas buyer: 1.2 million cubic feet a month at a fixed plant-gate price of $285 per Mcf, CPI escalation from March 2028, and a pricing redetermination in year three — with the buyer absorbing transport, logistics and volume risk. That is a helium offtake structure most sub-$100 million E&Ps could not dream of, and it is the single strongest fact in the dossier.

What slipped while the language stayed calm

Two milestones moved, and both moved by roughly a year. Go back to the May 2025 call. Asked whether plant completion could bleed past the first quarter of 2026, the CEO answered with weather small talk:

I think it's a weather thing really... it could be the end of the very first quarter, it could be the very beginning of the second quarter.

Ryan Smith, Chief Executive Officer · 2025-05-12
That was Q1/Q2 2026. This call targets spring 2027, described as a window rather than a date, with the reasoning that it "leaves sensible room for commissioning and for Montana winter." A twelve-month slip disclosed as prudence is still a twelve-month slip. The second is the Big Rose MRV plan. Submitted October 9, 2025; accepted by the EPA only on November 12, 2025 because of the federal government shutdown; now sitting in "final stage" of agency review with no date attached. In May the CEO was pressed on the expectation of approval "in that summer time period." Today: “historically, EPA approvals of comparable plans have generally taken 12 months or longer. So our timing is in line with precedent even if we had hoped for a quicker outcome.” — Ryan Smith, CEO · 2026-11-11 To management's credit, they have been consistent that this is not fatal: “Its impact is when we start generating and monetizing 45Q credits, not on the underlying economics of the project.” — Ryan Smith, CEO · 2026-11-11 That matches the August answer that MRV was never on the critical path to helium revenue. What the delay actually costs is timing on the credit stream — and with the balance sheet where it is, timing is not a footnote.

The multiple-arbitrage pitch meets the actual numbers

Here is the closing argument, delivered almost verbatim:

Small-cap E&P companies trade at roughly 3x EBITDA, midstream and gas processing at roughly 8x and blue-chip industrial gas companies at roughly 17x or higher. Those aren't our forecasts. They are public market multiples that anyone can verify. Our job is to keep executing the milestones and let the market award it.

Ryan Smith, CEO · 2026-11-11
It is an honest pitch, and the market has partly pre-paid it. Price to revenue sits at 6.8x — versus roughly 0.8–1.4x through 2023 and 2024. Investors have not waited for the plant. But the reported quarter is still an oil quarter, and a shrinking one. Revenue was $2 million, up 12% year over year on a 30% jump in realized price to $63.83 per BOE, against production of 30,628 BOE (76% oil). Adjusted EBITDA was negative $0.8 million. Net loss was $3.5 million, or $0.07 a share. Total revenue has fallen from an $11 million quarterly peak in late 2022 to roughly $2 million, and the trailing base business does not fund an industrial gas build. And there was a new, unwelcome item. Lease operating expense of $2.1 million included “approximately $1.2 million of remediation and related costs from the previously disclosed release of produced fluids from a gathering line in our legacy oil operations” — Mark Zajac, CFO · 2026-11-11. A $1 million insurance claim is pending over a $100,000 deductible, but no receivable was booked. The keyword remediation is new to this company's lexicon this quarter, and not in a good way. Liquidity is the reason all of this matters. Cash ended the quarter at $2.9 million, with $14.4 million of total liquidity including $11.5 million undrawn on a $20 million borrowing base that carries no covenant testing through March 2027 and matures May 2029. Effective net cash was $8 million at the last filed balance sheet, down from $11 million a year earlier. Management is running two parallel processes — a larger senior secured facility and 45Q monetization — and both are described as "progressing." Neither is signed. The CEO noted there are roughly two quarters of Phase 1 spend left, with a couple of million dollars added since the September 30 figure.

Where this connects to the wider tape

One detail deserves more attention than it got. The company chose to buy its own power generation rather than rent it — and the stated reason, on the August call, was that generators were the longest-lead item because they were “competing with data centers for power generation” — Ryan Smith, CEO or President · 2026-08-11. That is the same bottleneck showing up across the global tape this quarter, where data-center power demand dominates the advancers and decliners alike. Big Sky is a micro-cap on the wrong side of that trade opting out of it entirely; owning the gensets converts an uncontrollable input cost into a fixed asset, and management flags it as the one material capex increase versus plan. The 45Q effort has a lighter echo too — the broader market is currently pricing tax-credit value chains, with 45Z value surfacing among the market's top keywords this quarter and counterparties from GEVO to large insurers talking about credit monetization. Big Sky is small, but it is aiming at the same pool of buyers: big insurance, big tech, and institutions with large forecast tax burdens.

The verdict

The keyword rotation tells the story cleanly. Twelve months ago the deck was industrial gas ambition, Class II permits and a resource report. This quarter the top terms are Big Rose, critical material — the Department of Energy's October 23 designation of helium under the Energy Act of 2020, a genuine policy tailwind — plus civil work, infield gathering, long-lead equipment and a new senior secured credit facility. The language has moved from can we build this to when does it run and who funds the last mile. Notably, permit-centric words like Class II have fallen out of the top ranks entirely, which is appropriate: that work is done. What has not moved is the price chart. USEG is down 99.6% since 2010, with a peak of $423.60 in April 2010 and a 99.7% drawdown from it; over the last 90 days it is roughly flat after swinging from a 49% five-week decline into an 84% eleven-week rally. This is a binary, milestone-driven equity — a broken long-term chart waiting on a commissioning date. Fair summary: the field work is real, the offtake is real, and the DOE designation is real. But the two dates that would let the market underwrite the 17x multiple have both pushed out about a year, the 45Q cash that was supposed to be non-dilutive is still unsold, and the company is funding the gap on $2.9 million of cash plus a revolver. The pivot is credible; the calendar is not yet.